News | June 04, 2022
Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
Subscribe To Our Newsletter & Stay Updated
